Syphilis Testing Market to Witness High Growth in near future: Roche Diagnostics, Hologic, Inc., Becton Dickinson & Company, Abbott Laboratories, BioMerieux, Alere Inc., Cepheid Inc., Affymetrix, Inc. and Diasorin.

Syphilis is one of the vital sexually transmitted infections (STIs) caused by the bacteria named, Treponema pallidum, and can lead to long-term complications, if not diagnosed adequately. Syphilis continues to be a global health concern due to the increasing incidences occurring mainly among bisexuals and gay people. According to the World Health Organization (WHO), there were an estimated 36 million cases of syphilis in 2013 globally, with over 11 million new cases occurring annually.

Get the Sample Report: https://www.alliedmarketresearch.com/request-sample/675?utm_source=openpr&utm_medium=Niranjan

Syphilis Testing Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $3,650.3 million by 2020, registering a CAGR of 1.2% during the period 2014-2020. The secondary syphilis testing would continue to be the largest market segment through 2020. Latin America, Middle East&Africa(LAMEA) market accounted for about 43% revenue share of the syphilis testing market in 2014.

Rising Syphilis cases remain a vital public health issue and are a significant concern across the globe, especially in developing economies. The rising burden of syphilis incidences and the implementation of national screening programs are major factors fuelling the growth of Syphilis testing worldwide.

Furthermore, the growing adoption of novel technologies such as Enzyme Immunoassay (EIA) tests, Darkfield microscopy, and Microhemagglutination (MHA-TP) assay enables faster and improved screening results - thus provides an additional boost to the market growth. However, the social stigma associated with patients visiting STD clinics and large patient pool in remote areas would limit the market growth to a certain extent.

For Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/675?utm_source=openpr&utm_medium=Niranjan

LAMEA and the Asia Pacific constitute the two largest regions for syphilis testing market and collectively accounted for about 4/5th of the global revenue in 2014. Higher adoption rates for technologically advanced screening tests methods, active measures from governments and private associations along with the growing awareness of syphilis infections, largely contributes to the growth of the market in these regions.

Also, rising incidences of syphilis due to men having sex with men (MSM) and implementation of mandatory screening tests for all pregnant women would further foster the growth of syphilis testing market in these regions.

Key findings of Syphilis Testing Market:
• LAMEA will continue to lead the global market, closely followed by the Asia Pacific, all through the analysis period.
• The United States remains a major market in the North American syphilis testing market through 2020.
• Spain and Germany collectively account for about one-fourth of the Europe syphilis testing market.
• China and India collectively account for about 89% share in the Asia Pacific syphilis testing market.

Chapter: 3 MARKET OVERVIEW

3.1 Market Definition and Scope

3.2 Upcoming trends for Syphilis diagnostic testing market
3.2.1 Executing and ensuring accreditation for the qualification of participants in National Screening Programs around the globe.
3.2.2 Technological Advancements for Syphilis diagnostic testing market

3.3 Syphilis diagnostic tests

3.4 Key Findings
3.4.1 Top Factors Impacting global Syphilis diagnostic testing market
3.4.2 Top Investment Pockets of global Syphilis diagnostic testing market (2014-2020)
3.4.3 Top winning strategies of global Syphilis diagnostic testing market

3.5 Government Regulations and reimbursement scenario
3.5.1 Government Regulation
3.5.2 Reimbursement policies for Syphilis testing

3.6 Value Chain Analysis
3.6.1 Primary Activities
3.6.2 Supportive Activities

3.7 Market dynamics
3.7.1 Drivers
3.7.1.1 Growing incidence rates and increasing prevalence rates of Syphilis
3.7.1.2 Implementation of National Screening Programs
3.7.1.3 Supporting Reimbursement for Syphilis testing
3.7.2 Restraints
3.7.2.1 Social stigma associated with patients visiting specialized STD clinics.
3.7.2.2 Huge proportion of patients infected with Syphilis in remote areas.
3.7.2.3 Stringent regulatory abidance requirements for the participants of the Syphilis market
3.7.3 Opportunities
3.7.3.1 Decreasing number of visits to GUM clinics and specialized STD clinics
3.7.3.2 National screening Programs across the globe
3.7.3.3 Niche opportunities for technology and POC test providers in emerging economies

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.